Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000131069 | SCV000185999 | benign | Hereditary cancer-predisposing syndrome | 2019-01-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000131069 | SCV000292088 | benign | Hereditary cancer-predisposing syndrome | 2014-11-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000245575 | SCV000309255 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Counsyl | RCV000409134 | SCV000488799 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2016-06-18 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000409134 | SCV000884439 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2024-11-06 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000409134 | SCV001440195 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000409134 | SCV001717669 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705932 | SCV001841070 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28202063) |
Myriad Genetics, |
RCV000409134 | SCV004044159 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2023-05-10 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Breakthrough Genomics, |
RCV001705932 | SCV005253873 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics Laboratory, |
RCV000245575 | SCV001906259 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000245575 | SCV001951768 | benign | not specified | no assertion criteria provided | clinical testing |